Lu-177 has been developed for the treatment of patients with peptide receptor radionuclide
therapy (PRRT). A second generation pure no-carrier-added Lu-177 has a high specific …

Simple Summary Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors,
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …

Simple Summary Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of
tumors arising in different organs whose clinical course is variable according to histological …

Simple Summary Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a
group of tumors with different clinical manifestations, various localizations in the human …

Background Chronotype is defined as a trait determining the subject circadian preference in
behavioral and biological rhythms relative to external light–dark cycle. Although individual …

Neuroendocrine tumors (NETs) are an uncommon, heterogeneous group of tumors arising
from cells of neuroendocrine origin, which can be found at multiple sites throughout the …

Simple Summary The capecitabine/temozolomide (CAPTEM) regimen has proven activity in
pancreatic neuroendocrine tumors (NETs); however, data are limited in NETs of the small …

The genetic characteristics of rectal neuroendocrine tumors (R-NETs) were poorly
understood. Depicting the genetic characteristics may provide a biological basis for …

Somatostatin (SST)/somatotropin release-inhibiting factor (SRIF) is a well-known
neuropeptide, widely distributed in the central and peripheral nervous systems, that …

Objective: This study aimed at assessing the impact of surgical treatments in patients with
gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Methods: A propensity score …